Need professional-grade analysis? Visit stockanalysis.com
$251.20M
20.95
N/A
N/A
OpGen Inc (OPGN) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $23.00, down 2.13% from the previous close.
Over the past year, OPGN has traded between a low of $0.00 and a high of $34.00. The stock has gained 369.4% over this period. It is currently 32.4% below its 52-week high.
OpGen Inc has a market capitalization of $251.20M, with a price-to-earnings ratio of 20.95.
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
Side-by-side comparison against top Healthcare peers.